Latest News and Press Releases

Dublin, May 13, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trial Monitoring Training Course" training has been added to ResearchAndMarkets.com's offering. This course will benefit those involved in...

Recipharm and ProductLife Group announce a strategic collaboration aimed at supporting (bio)pharmaceutical companies.

Dublin, May 12, 2025 (GLOBE NEWSWIRE) -- The "Virtual Seminar on The EU Clinical Trial Regulation - EU Filings & Registrations (ONLINE EVENT: May 28, 2025)" has been added to ...

MaxisIT rebrands as Maxis AI, unveiling an enterprise-grade Agentic AI platform to accelerate clinical trials through intelligent, compliant automation.

GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty...

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Malaria - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides an overview of...

Yamo Pharma's Phase 2 data at INSAR 2025 show L1-79 delivers statistically significant and clinically meaningful improvements in core autism symptoms.

MELBOURNE, Australia and SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing...

Avance Clinical, the award-winning, global CRO for biotechs, is proud to announce its sponsorship of the Citeline Awards 2025 tomorrow in Boston.

Pasithea Therapeutics (Nasdaq: KTTA) prices $5M public offering to fund clinical trials, R&D, and corporate initiatives; closing expected May 7, 2025.